JBT Marel Corporation <JBTM.N>: Barclays initiates coverage with overweight rating and target price $150
JBTM•Related News
UiPath, Inc. <PATH.N>: Barclays raises target price to $17 from $14
PATH•
OS Therapies reports 71.2% 3-year survival in Phase 2b OST-HER2 metastatic osteosarcoma trial
OSTX•
Merck & Co Inc <MRK.N>: Guggenheim raises target price to $170 from $146
MRK•
Citigroup Raises CPU TAM Forecast to $237 Bln by 2030, From Prior Forecast of $137 Bln
SOXX•
Yum China files HKEX next-day return disclosing share buyback for cancellation
YUMC•